Detection of Clostridium botulinum type a by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals
DEZFULIAN M., BARTLETT J.G.: Detection of Clostridium botulinum type A by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals. J.Clin.Microbiol. 19, 645-648 (1984).
Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization
DEZFULIAN M., BARTLETT J.G.: Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization. Diagn.Matchable Infect.Dis. 2, 105-112 (1985a).
Selective isolation and rapid identification of Clostridium botulinum type a and B by toxin detection
DEZFULIAN M., BARTLETT J.G.: Selective isolation and rapid identification of Clostridium botulinum type A and B by toxin detection. J.Clin.Microbiol. 21, 2361-2363 (1985b).
Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type a and type B toxins in stool samples of infants with botulism
DEZFULIAN M., HATHAWAY C.L., YOLKEN R.H., BARTLETT J G.: Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type A and type B toxins in stool samples of infants with botulism. J.Clin.Microbiol. 20, 379-383 (1984).
Selective medium for isolation of Clostridium botulinum from human feces
DEZFULIAN M., MCCROSKEY L.M., HATHAWAY C.L., DOWELL V.R. Jr.: Selective medium for isolation of Clostridium botulinum from human feces. J.Clin.Microbiol. 13, 526-531 (1981).
Laboratory diagnosis of botulism complicated by pyridostigmine treatment of the patient - A method for selectively removing interfering substances from clinical specimens
HORWITZ M.A., HATHAWAY C.L., DOWELL V.R. Jr.: Laboratory diagnosis of botulism complicated by pyridostigmine treatment of the patient - a method for selectively removing interfering substances from clinical specimens. Am.J.Clin.Path. 66, 737 (1976).